Variability of ferritin measurements in chronic kidney disease; implications for iron management

被引:47
|
作者
Ford, Bradley A. [1 ]
Coyne, Daniel W. [2 ]
Eby, Charles S. [1 ,2 ]
Scott, Mitchell G. [1 ]
机构
[1] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Dept Med, St Louis, MO 63110 USA
关键词
ferritin; iron; hemodialysis; anemia; ANEMIC HEMODIALYSIS-PATIENTS; HIGH SERUM FERRITIN; INTRAVENOUS IRON; TRANSFERRIN SATURATION; DIALYSIS PATIENTS; IV IRON; DEFICIENCY; GLUCONATE; TRIAL; REDUCTION;
D O I
10.1038/ki.2008.526
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Serum ferritin levels are a proxy measure of iron stores; existing guidelines for managing anemia in hemodialysis patients suggest that serum ferritin concentrations should be maintained at > 200 ng/ml. The KDOQI recommendations further state there is insufficient evidence advocating routine intravenous iron when ferritin levels exceed 500 ng/ml. Here we determined the interassay differences and short-term intraindividual variability of serum ferritin measurements in patients on chronic hemodialysis to illustrate how these variances may affect treatment decisions. Intermethod variations of up to 150 ng/ml were found comparing six commonly used ferritin assays that evaluated thirteen pools of serum from hemodialysis and nonhemodialysis patients. The intraindividual variability for ferritin in 60 stable hemodialysis patients ranged between 2-62% measured over an initial two-week period and from 3-52% when factored over a six-week period. Our results suggests that single serum ferritin values should not be used to guide clinical decisions regarding treatment of chronic hemodialysis patients with intravenous iron due to significant analytical and intraindividual variability.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 50 条
  • [31] Iron supplementation to treat anemia in patients with chronic kidney disease
    Besarab, Anatole
    Coyne, Daniel W.
    NATURE REVIEWS NEPHROLOGY, 2010, 6 (12) : 699 - 710
  • [32] Iron Status and Inflammation in Early Stages of Chronic Kidney Disease
    Lukaszyk, Ewelina
    Lukaszyk, Mateusz
    Koc-Zorawska, Ewa
    Tobolczyk, Jolanta
    Bodzenta-Lukaszyk, Anna
    Malyszko, Jolanta
    KIDNEY & BLOOD PRESSURE RESEARCH, 2015, 40 (04) : 366 - 373
  • [33] Diagnosis of Iron-Deficiency Anemia in Chronic Kidney Disease
    Bahrainwala, Jehan
    Berns, Jeffrey S.
    SEMINARS IN NEPHROLOGY, 2016, 36 (02) : 94 - 98
  • [34] Iron dosing in kidney disease: inconsistency of evidence and clinical practice
    Gaweda, Adam E.
    Ginzburg, Yelena Z.
    Chait, Yossi
    Germain, Michael J.
    Aronoff, George R.
    Rachmilewitz, Eliezer
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (02) : 187 - 196
  • [35] Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
    Macdougall, Iain C.
    Bircher, Andreas J.
    Eckardt, Kai-Uwe
    Obrador, Gregorio T.
    Pollock, Carol A.
    Stenvinkel, Peter
    Swinkels, Dorine W.
    Wanner, Christoph
    Weiss, Guenter
    Chertow, Glenn M.
    KIDNEY INTERNATIONAL, 2016, 89 (01) : 28 - 39
  • [36] Heme iron polypeptide for the management of anaemia of chronic kidney disease
    Dull, R. B.
    Davis, E.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (04) : 386 - 390
  • [37] Iron Overload in Chronic Kidney Disease: Less Ferritin, More T2*MRI
    Nashwan, Abdulqadir J.
    Yassin, Mohamed A.
    Ibrahim, Mohamed Izham Mohamed
    Abdul Rahim, Hanan F.
    Shraim, Mujahed
    FRONTIERS IN MEDICINE, 2022, 9
  • [38] Iron Deficiency Anemia in Chronic Kidney Disease
    Gaiter-Gvili, Anat
    Schechter, Amir
    Rozen-Zvi, Benaya
    ACTA HAEMATOLOGICA, 2019, 142 (01) : 44 - 50
  • [39] Iron and Chronic Kidney Disease: Still a Challenge
    Wojtaszek, Ewa
    Glogowski, Tomasz
    Malyszko, Jolanta
    FRONTIERS IN MEDICINE, 2020, 7
  • [40] Measurement of iron status in chronic kidney disease
    Wesley Hayes
    Pediatric Nephrology, 2019, 34 : 605 - 613